These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 26526036)
1. Predictors of Early Discontinuation of Effective Contraception by Teens at High Risk of Pregnancy. Maslyanskaya S; Coupey SM; Chhabra R; Khan UI J Pediatr Adolesc Gynecol; 2016 Jun; 29(3):269-75. PubMed ID: 26526036 [TBL] [Abstract][Full Text] [Related]
2. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion. Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190 [TBL] [Abstract][Full Text] [Related]
3. Postpartum contraception: initiation and effectiveness in a large universal healthcare system. Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962 [TBL] [Abstract][Full Text] [Related]
4. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system. Chiles DP; Roberts TA; Klein DA Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514 [TBL] [Abstract][Full Text] [Related]
5. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review. Usinger KM; Gola SB; Weis M; Smaldone A J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):659-667. PubMed ID: 27386754 [TBL] [Abstract][Full Text] [Related]
6. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch? Thurman AR; Hammond N; Brown HE; Roddy ME J Pediatr Adolesc Gynecol; 2007 Apr; 20(2):61-5. PubMed ID: 17418388 [TBL] [Abstract][Full Text] [Related]
7. Comparison of continuation rates for hormonal contraception among adolescents. Zibners A; Cromer BA; Hayes J J Pediatr Adolesc Gynecol; 1999 May; 12(2):90-4. PubMed ID: 10326194 [TBL] [Abstract][Full Text] [Related]
8. Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial. Akello CA; Bunge KE; Nakabiito C; Mirembe BG; Fowler MG; Mishra A; Marrazzo J; Chirenje ZM; Celum C; Balkus JE J Womens Health (Larchmt); 2017 Jun; 26(6):670-676. PubMed ID: 28437215 [TBL] [Abstract][Full Text] [Related]
9. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial. Hubacher D; Spector H; Monteith C; Chen PL; Hart C Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799 [TBL] [Abstract][Full Text] [Related]
10. Predictors of contraceptive switching and discontinuation within the first 6 months of use among Highly Effective Reversible Contraceptive Initiative Salt Lake study participants. Simmons RG; Sanders JN; Geist C; Gawron L; Myers K; Turok DK Am J Obstet Gynecol; 2019 Apr; 220(4):376.e1-376.e12. PubMed ID: 30576664 [TBL] [Abstract][Full Text] [Related]
11. Young men's awareness and knowledge of intrauterine devices in the United States. Marshall CJ; Gomez AM Contraception; 2015 Nov; 92(5):494-500. PubMed ID: 26169342 [TBL] [Abstract][Full Text] [Related]
12. Improved continuation rate of depot-medroxyprogesterone acetate in adolescent mothers. Omar H; Fowler A; D'Angelo S Int J Adolesc Med Health; 2002; 14(2):149-52. PubMed ID: 12467187 [TBL] [Abstract][Full Text] [Related]
13. Choice of Postpartum Contraception: Factors Predisposing Pregnant Adolescents to Choose Less Effective Methods Over Long-Acting Reversible Contraception. Chacko MR; Wiemann CM; Buzi RS; Kozinetz CA; Peskin M; Smith PB J Adolesc Health; 2016 Jun; 58(6):628-35. PubMed ID: 26852250 [TBL] [Abstract][Full Text] [Related]
14. One-year contraceptive continuation and pregnancy in adolescent girls and women initiating hormonal contraceptives. Raine TR; Foster-Rosales A; Upadhyay UD; Boyer CB; Brown BA; Sokoloff A; Harper CC Obstet Gynecol; 2011 Feb; 117(2 Pt 1):363-371. PubMed ID: 21252751 [TBL] [Abstract][Full Text] [Related]
15. Twenty-four-month continuation of reversible contraception. O'Neil-Callahan M; Peipert JF; Zhao Q; Madden T; Secura G Obstet Gynecol; 2013 Nov; 122(5):1083-1091. PubMed ID: 24104781 [TBL] [Abstract][Full Text] [Related]